News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
389,965 Results
Type
Article (24335)
Company Profile (299)
Press Release (365331)
Section
Business (112604)
Career Advice (716)
Deals (20410)
Drug Delivery (59)
Drug Development (63046)
Employer Resources (88)
FDA (8912)
Job Trends (7848)
News (203064)
Policy (16032)
Tag
2024 BioCapital Digital (6)
2024 BioForest Digital (1)
2024 BioMidwest Digital (6)
2024 Bio NC Digital (5)
2024 Bio NC Standard (1)
2024 Biotech Bay Standard (12)
2024 Biotech Beach Digital (5)
2024 Biotech Beach Standard (4)
2024 Genetown Digital (7)
2024 Genetown Standard (9)
2024 Lone Star Bio Digital (5)
2024 Pharm Country Digital (4)
2024 Pharm Country Standard (6)
2025 BioForest Digital (3)
2025 Lone Star Bio Digital (3)
2026 BioMidwest Elite (1)
2026 Biotech Bay Elite (1)
2026 Biotech Bay Standard (1)
2026 Biotech Beach Elite (1)
2026 Genetown Elite (2)
2026 Pharm Country Elite (1)
2026 Pharm Country Premier (1)
2026 Pharm Country Standard (1)
Academia (1680)
Academic (1)
Accelerated approval (3)
Adcomms (16)
Allergies (63)
Alliances (30654)
ALS (75)
Alzheimer's disease (1044)
Antibody-drug conjugate (ADC) (98)
Approvals (8927)
Artificial intelligence (146)
Autoimmune disease (17)
Automation (6)
Bankruptcy (161)
Best Places to Work (6577)
BIOSECURE Act (9)
Biosimilars (55)
Biotechnology (238)
Bladder cancer (50)
Brain cancer (23)
Breast cancer (183)
Cancer (1555)
Cardiovascular disease (137)
Career advice (600)
Career pathing (13)
CAR-T (117)
Cell therapy (333)
Cervical cancer (14)
Clinical research (51502)
Collaboration (585)
Compensation (242)
Complete response letters (15)
COVID-19 (1719)
CRISPR (37)
C-suite (168)
Cystic fibrosis (83)
Data (1650)
Denatured (16)
Depression (37)
Diabetes (191)
Diagnostics (2674)
Digital health (6)
Diversity (5)
Diversity, equity & inclusion (31)
Drug discovery (91)
Drug pricing (61)
Drug shortages (18)
Duchenne muscular dystrophy (87)
Earnings (40275)
Editorial (25)
Employer branding (9)
Employer resources (81)
Events (62612)
Executive appointments (508)
FDA (9693)
Featured Employer (36)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (7)
Funding (539)
Gene editing (92)
Generative AI (12)
Gene therapy (256)
GLP-1 (569)
Government (1941)
Grass and pollen (3)
Guidances (24)
Healthcare (10634)
Huntington's disease (21)
IgA nephropathy (24)
Immunology and inflammation (89)
Indications (22)
Infectious disease (1812)
Inflammatory bowel disease (122)
Inflation Reduction Act (10)
Influenza (30)
Intellectual property (67)
Interviews (117)
IPO (9594)
IRA (27)
Job creations (1614)
Job search strategy (536)
Kidney cancer (7)
Labor market (8)
Layoffs (255)
Leadership (7)
Legal (2985)
Liver cancer (42)
Lung cancer (210)
Lymphoma (97)
Machine learning (2)
Management (26)
Manufacturing (162)
MASH (56)
Medical device (5321)
Medtech (5324)
Mergers & acquisitions (11175)
Metabolic disorders (507)
Multiple sclerosis (63)
NASH (17)
Neurodegenerative disease (70)
Neuropsychiatric disorders (24)
Neuroscience (1476)
NextGen: Class of 2025 (3519)
Non-profit (2194)
Northern California (1750)
Now hiring (22)
Obesity (267)
Opinion (135)
Ovarian cancer (64)
Pain (56)
Pancreatic cancer (59)
Parkinson's disease (121)
Partnered (12)
Patents (133)
Patient recruitment (80)
Peanut (40)
People (36260)
Pharmaceutical (55)
Pharmacy benefit managers (11)
Phase I (16347)
Phase II (23080)
Phase III (16726)
Pipeline (849)
Podcasts (54)
Policy (71)
Postmarket research (1678)
Preclinical (6820)
Press Release (61)
Prostate cancer (74)
Psychedelics (37)
Radiopharmaceuticals (224)
Rare diseases (307)
Real estate (2599)
Recruiting (33)
Regulatory (12435)
Reports (20)
Research institute (1534)
Resumes & cover letters (94)
Rett syndrome (4)
RNA editing (4)
RSV (26)
Schizophrenia (62)
Series A (102)
Series B (67)
Service/supplier (3)
Sickle cell disease (41)
Southern California (1548)
Special edition (12)
Spinal muscular atrophy (132)
Sponsored (13)
Startups (2562)
State (1)
Stomach cancer (6)
Supply chain (30)
Tariffs (8)
The Weekly (37)
United States (14488)
Vaccines (425)
Venture capitalists (30)
Webinars (9)
Weight loss (163)
Women's health (25)
Worklife (7)
Date
Today (78)
Last 7 days (538)
Last 30 days (1947)
Last 365 days (23911)
2025 (5847)
2024 (24848)
2023 (27543)
2022 (34699)
2021 (36632)
2020 (32622)
2019 (26046)
2018 (19485)
2017 (20124)
2016 (18425)
2015 (22253)
2014 (16170)
2013 (12181)
2012 (12613)
2011 (12909)
2010 (11925)
Location
Africa (352)
Alabama (40)
Alaska (4)
Arizona (81)
Arkansas (7)
Asia (25068)
Australia (4370)
California (3971)
Canada (1247)
China (377)
Colorado (164)
Connecticut (167)
Delaware (102)
Europe (63859)
Florida (505)
Georgia (155)
Idaho (30)
Illinois (306)
India (15)
Indiana (162)
Iowa (4)
Japan (105)
Kansas (67)
Kentucky (12)
Louisiana (6)
Maine (19)
Maryland (562)
Massachusetts (3131)
Michigan (97)
Minnesota (191)
Mississippi (1)
Missouri (40)
Montana (17)
Nebraska (10)
Nevada (27)
New Hampshire (21)
New Jersey (1096)
New Mexico (17)
New York (1160)
North Carolina (635)
North Dakota (4)
Northern California (1750)
Ohio (126)
Oklahoma (12)
Oregon (25)
Pennsylvania (797)
Puerto Rico (5)
Rhode Island (17)
South America (531)
South Carolina (10)
Southern California (1548)
Tennessee (37)
Texas (518)
Utah (61)
Virginia (90)
Washington D.C. (32)
Washington State (387)
Wisconsin (20)
389,965 Results for "peptide therapeutics group plc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Cybrexa Therapeutics Announces New Preclinical Data on Tumor-Selective Peptide-Drug Conjugates at ESMO Targeted Anticancer Therapies Congress 2025
March 4, 2025
·
4 min read
Press Releases
CordenPharma and Viking Therapeutics Sign Long-Term Strategic Partnership for Integrated Supply of GLP-1 Peptides, Injectables and Oral Formulations
March 11, 2025
·
3 min read
Press Releases
Hemogenyx Pharmaceuticals PLC Announces FDA Annual Report
April 3, 2025
·
3 min read
Press Releases
Awakn Life Sciences Enters into Arrangement Agreement for The Acquisition of Awakn by Solvonis Therapeutics plc
February 27, 2025
·
13 min read
Press Releases
Hemogenyx Pharmaceuticals PLC Announces Recruitment of Second Patient for Clinical Trials
March 17, 2025
·
2 min read
Press Releases
Sai Life Sciences sets up Peptide Research Center in India
April 3, 2025
·
2 min read
Business
Secarna Pharmaceuticals and Orbit Discovery Enter Collaboration to Discover and Develop Peptide-conjugated Targeted Antisense Oligonucleotide Therapeutics
Secarna Pharmaceuticals GmbH & Co. KG and Orbit Discovery Ltd. today announced that they have entered into a collaboration to discover and develop peptide-conjugated targeted antisense oligonucleotide (ASO) therapeutics.
May 28, 2024
·
2 min read
Hemogenyx Pharmaceuticals PLC Announces Operations Update - June 17, 2024
Hemogenyx Pharmaceuticals plc, the clinical stage biopharmaceutical group developing treatments for cancers and viral diseases, is pleased to provide an update on its ongoing activities and progress.
June 17, 2024
·
4 min read
Horizon Therapeutics plc Ranks First in Overall Corporate Reputation by Rare Disease Patient Advocacy Groups
Horizon Therapeutics plc (Nasdaq: HZNP) today announced that it ranked first in overall corporate reputation among rare disease patient groups around the world who were familiar with the company.
August 23, 2023
·
4 min read
Press Releases
Barinthus Biotherapeutics plc to Present at the Investor Summit Virtual on March 11
March 6, 2025
·
1 min read
1 of 38,997
Next
